Cascadian Therapeutics, Inc.
Industrials · Services-Commercial Physical & Biological Research · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$58.1M | −$64.8M | −$32.8M | −$50.8M | −$41.2M | −$28.5M |
| Net income | −$12.4M | −$12.9M | −$32.6M | −$50.0M | −$38.8M | −$3.4M |
| Total assets | $120.8M | $83.3M | $96.6M | $103.1M | $77.7M | $89.4M |
| Total liabilities | — | — | — | — | $6.2M | $7.1M |
| Equity | $109.0M | $74.4M | $83.7M | $91.3M | $71.5M | $82.3M |
| EPS (diluted) | — | — | — | $-0.64 | $-0.62 | $-0.53 |
| Shares out. | 49.2M | 95.0M | 106.3M | 70.7M | 57.2M | 43.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- —
- Net margin
- —
- Return on equity
- −11.4%
- Return on assets
- −10.2%
- Return on capital (ROCE)
- −53.3%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $2.22
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Accruals / assets
- 31.1%high accruals
- Piotroski F-Score
- 3/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 2 warning● 0 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 9, 2012
- NT 10-Kmissed a reporting deadline ↗Mar 16, 2010
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer changeMar 9, 2018
- Director / officer changeFeb 7, 2018
- Entered a material agreement · Amended charter or bylaws · Other material eventJan 31, 2018
- Entered a material agreement · Terminated a material agreementDec 7, 2017
- Results of operationsNov 8, 2017
- Results of operationsAug 8, 2017
- Amended charter or bylaws · Shareholder voteJun 9, 2017
- Results of operationsMay 9, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- CT ORDERApr 11, 2019
- CT ORDERMay 22, 2018
- SC 13G/ANONEApr 9, 2018
- 15-12BMar 22, 2018
- EFFECTMar 21, 2018
- EFFECTMar 21, 2018
- EFFECTMar 21, 2018
- EFFECTMar 21, 2018
- SC 13D/AGROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- CASCADIAN THERAPEUTICS, INC. - SCHEMar 19, 2018
- 4FORM 4 SUBMISSIONMar 13, 2018
- 4FORM 4 SUBMISSIONMar 13, 2018
- 4FORM 4 SUBMISSIONMar 13, 2018
- 4FORM 4 SUBMISSIONMar 13, 2018
- 4FORM 4 SUBMISSIONMar 13, 2018
- 4FORM 4 SUBMISSIONMar 13, 2018
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.